Arquivos do dia: Setembro 2, 2021

[Preprint] Estudos randomizados sobre intervenções não farmacológicas (INF) para COVID-19 até agosto de 2021: uma metanálise epidemiológica – “Ao redor do mundo, 41 estudos randomizados avaliando as INF tiveram início, mas há resultados publicados e disponíveis para balizar decisões de políticas para somente 7 deles.”

2 Set, 2021 | 11:52h

Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis – medRxiv

 

Comentário no Twitter

New Preprint: Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis@BessiCollab @CovidEvidence https://t.co/xZsgqegSRR

1/n

— Lars G. Hemkens (@LGHemkens) August 31, 2021

 

---

[Preprint] Dose de proteção e reforço da vacina da Pfizer: um estudo nacional de Israel – “Doze dias ou mais depois da dose de reforço, observou-se uma redução de 11,4 vezes no risco relativo de infecção confirmada e redução acima de 10 vezes no risco relativo de doença grave.

2 Set, 2021 | 11:51h

BNT162b2 vaccine booster dose protection: A nationwide study from Israel – medRxiv

---

Por que a terceira dose de vacina contra COVID-19 é importante para pessoas imunocomprometidas?

2 Set, 2021 | 11:49h

Why is a third COVID-19 vaccine dose important for people who are immunocompromised? – The Conversation

Conteúdos relacionados:

FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.

RCT: third dose of Moderna mRNA vaccine increases immunity in transplant recipients.

Study: Among kidney transplant recipients who did not respond after 2 doses, a third dose of an mRNA-1273 vaccine induced a serologic response in 49% of patients.

Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.

---

Perspectiva | Reforços da vacina contra COVID-19 em nações ricas atrasará a vacinação para todos.

2 Set, 2021 | 11:48h

COVID-19 boosters in rich nations will delay vaccines for all – Nature

 

Comentários no Twitter

In @NatureMedicine, @zchagla & I ask:

Are we as a species willing to protect all humankind, or do we mostly care about optimizing protection for people in wealthy nations?https://t.co/LCS5Dxf1II pic.twitter.com/vdn4oRiYyz

— Madhu Pai, MD, PhD (@paimadhu) August 31, 2021

"There remain 3.5 billion people on this earth, nearly half of the world’s population, who have not received even a first dose of vaccine. Only 2% of the African population has received even a single dose." #Equity #COVID19 Via @NatureMedicine https://t.co/k6cG6vyQ5d pic.twitter.com/DsbWVvQ9R7

— Muin J. Khoury (@MuinJKhoury) August 31, 2021

Prioritising COVID booster shots in high income countries is unethical – until health care workers and those at high risk in low and middle income countries have been vaccinated. @paimadhu and @zchagla wrote this much better than I could – thank you! https://t.co/F89o8y9V8P

— Ben Johnson 🦠📝 (@drbenjohnson) August 31, 2021

 

---

Estudo mostra que pacientes com COVID-19 têm risco mais alto de desenvolver coágulos após cirurgia.

2 Set, 2021 | 11:46h

COVID-19 patients at higher risk of blood clots after surgery, study shows – CIDRAP

Estudo original: SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study – Anaesthesia

Conteúdos relacionados:

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

WSES Position Paper: The management of surgical patients in the emergency setting during COVID-19 pandemic

Preparing previously COVID-19-positive patients for elective surgery: A framework for preoperative evaluation

---

Estudo | Pacientes, e não a equipe, são a maior fonte de disseminação hospitalar de COVID.

2 Set, 2021 | 11:44h

Study: Patients, not staff, source of most hospital COVID spread – CIDRAP

Artigo original: Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections – eLife

---

COVID pode ser mais infecciosa nos 2 ou 3 dias próximos ao início dos sintomas.

2 Set, 2021 | 11:43h

COVID may be most infectious 2 or 3 days around symptom onset – CIDRAP

Artigo original: COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: A Population-Based Cohort Study in Zhejiang Province, China – JAMA Internal Medicine

---

Diretriz NICE | Avaliação e tratamento da doença renal crônica.

2 Set, 2021 | 11:41h

Chronic kidney disease: assessment and management – National Institute for Health and Care Excellence

---

Atualização de diretriz de prática clínica da AGA para o diagnóstico e o tratamento da gastrite atrófica.

2 Set, 2021 | 11:40h

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review – Gastroenterology

 

Comentário no Twitter

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis 👌🏻👌🏻@AGA_Gastro @AmerGastroAssn #GITwitter https://t.co/MihpPoVR2b pic.twitter.com/e3MJ6aIQML

— Dr. Eric Kauffman Ortega (@eric_kauff) August 26, 2021

 

---

Recomendações de 2021 para os padrões de monitoramento durante a anestesia e na recuperação.

2 Set, 2021 | 11:38h

Recommendations for standards of monitoring during anaesthesia and recovery 2021 – Anaesthesia

---